Vivos Therapeutics Inc

NASDAQ:VVOSUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.

Contact Information

Headquarters

7921 Southpark Plaza,, Suite 210LITTLETON, CO, United States 80120

Phone

---

Fax

302-655-5049

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder

R. Kirk Huntsman

Chief Financial Officer

Bradford Amman

Independent Director

Ralph Green

Independent Director

Anja Krammer

Independent Director

Mark Lindsay